Yes, a translation is required for submitting a Drug Master File (DMF) in China. All documents must be in Chinese, as per the National Medical Products Administration (NMPA) regulations. This ensures clarity and compliance with local regulatory standards, facilitating the review and approval process for pharmaceutical products.